ETX — E-Therapeutics Share News
0.000.00%
- £54.93m
- £23.53m
- £0.48m
Total Voting Rights
Director Dealing and Issue of Equity
Second Price Monitoring Extn
Price Monitoring Extension
Price Monitoring Extension
Total Voting Rights
Holding(s) in Company
Holding(s) in Company
Holding(s) in Company
AIM - AIM Notice - 06/10/2022
Brief: e-Therapeutics Announces Fundraise Of £13.5 Mln Via Subscription
Brief: e-Therapeutics Posts HY Loss After Tax Of £3.8 Mln
Interim results for the six months to 31 July 2022
Fundraise of £13.5 million by way of Subscription
Second Price Monitoring Extn
Price Monitoring Extension
Brief: E-Therapeutics Files Eight Patent Applications
Filing of eight patent applications
Total Voting Rights